Content
@
https://opensea.io/collection/science-14
0 reply
0 recast
0 reaction
arob.base.eth
@arob1000
Very excited to announce that we’ve dosed our first patient with our latest next-gen cancer immunotherapy drug which is broadly applicable to most solid tumors! We started working on this one in 2022. It’s really cool to see how quickly a drug can go from an idea into the clinic. https://investors.vir.bio/news/news-details/2025/Vir-Biotechnology-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-EGFR-Targeting-PRO-XTEN-Dual-Masked-T-Cell-Engager-VIR-5525-for-the-Treatment-of-Solid-Tumors/default.aspx
11 replies
8 recasts
29 reactions
Manu Williams 🎩🔵🏒
@manuwilliams
That’s great progress Arob! I hope it is successful! 431 $degen
0 reply
0 recast
0 reaction
